Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Alzheimer's Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 324 articles:
HTML format



Single Articles


    January 2020
  1. KWAK DE, Ko T, Koh HS, Ji YW, et al
    Alterations of aqueous humor Abeta levels in Abeta-infused and transgenic mouse models of Alzheimer disease.
    PLoS One. 2020;15:e0227618.
    PubMed     Abstract available


  2. WESTMAN G, Schoofs C, Ingelsson M, Jarhult JD, et al
    Torque teno virus viral load is related to age, CMV infection and HLA type but not to Alzheimer's disease.
    PLoS One. 2020;15:e0227670.
    PubMed     Abstract available


  3. HAIDER S, Liaquat L, Ahmad S, Batool Z, et al
    Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress.
    PLoS One. 2020;15:e0227631.
    PubMed     Abstract available


  4. DOWNER B, Al Snih S, Raji M, Chou LN, et al
    Healthcare utilization of Mexican-American Medicare beneficiaries with and without Alzheimer's disease and related dementias.
    PLoS One. 2020;15:e0227681.
    PubMed     Abstract available


  5. BLOCH K, Hornfeld SH, Dar S, Vanichkin A, et al
    Long-term effects of intracranial islet grafting on cognitive functioning in a rat metabolic model of sporadic Alzheimer's disease-like dementia.
    PLoS One. 2020;15:e0227879.
    PubMed     Abstract available


  6. MAO Y, Fisher DW, Yang S, Keszycki RM, et al
    Protein-protein interactions underlying the behavioral and psychological symptoms of dementia (BPSD) and Alzheimer's disease.
    PLoS One. 2020;15:e0226021.
    PubMed     Abstract available


  7. LIAO JY, Lee CT, Lin TY, Liu CM, et al
    Exploring prior diseases associated with incident late-onset Alzheimer's disease dementia.
    PLoS One. 2020;15:e0228172.
    PubMed     Abstract available


  8. SUN YQ, Richmond RC, Chen Y, Mai XM, et al
    Mixed evidence for the relationship between periodontitis and Alzheimer's disease: A bidirectional Mendelian randomization study.
    PLoS One. 2020;15:e0228206.
    PubMed     Abstract available


  9. LEE EG, Tulloch J, Chen S, Leong L, et al
    Redefining transcriptional regulation of the APOE gene and its association with Alzheimer's disease.
    PLoS One. 2020;15:e0227667.
    PubMed     Abstract available


  10. OH AJ, Amore G, Sultan W, Asanad S, et al
    Correction: Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer's disease.
    PLoS One. 2020;15:e0230061.
    PubMed     Abstract available


  11. WANG G, Kennedy RE, Goldberg TE, Fowler ME, et al
    Using practice effects for targeted trials or sub-group analysis in Alzheimer's disease: How practice effects predict change over time.
    PLoS One. 2020;15:e0228064.
    PubMed     Abstract available


  12. ORIMAYE SO, Goodkin K, Riaz OA, Salcedo JM, et al
    A machine learning-based linguistic battery for diagnosing mild cognitive impairment due to Alzheimer's disease.
    PLoS One. 2020;15:e0229460.
    PubMed     Abstract available


  13. BARTHOLD D, Joyce G, Diaz Brinton R, Wharton W, et al
    Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
    PLoS One. 2020;15:e0229541.
    PubMed     Abstract available


  14. LI X, Yang X, Sun Z
    Alpha rhythm slowing in a modified thalamo-cortico-thalamic model related with Alzheimer's disease.
    PLoS One. 2020;15:e0229950.
    PubMed     Abstract available


  15. MARZBAN EN, Eldeib AM, Yassine IA, Kadah YM, et al
    Alzheimer's disease diagnosis from diffusion tensor images using convolutional neural networks.
    PLoS One. 2020;15:e0230409.
    PubMed     Abstract available


  16. ZHOU M, Xu R, Kaelber DC, Gurney ME, et al
    Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.
    PLoS One. 2020;15:e0229819.
    PubMed     Abstract available


  17. SHANG Y, Mishra A, Wang T, Wang Y, et al
    Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice.
    PLoS One. 2020;15:e0225392.
    PubMed     Abstract available


  18. IMAI H, Hirai T, Kumazawa R, Nakagawa S, et al
    Prevalence of and risk factors for adverse events in Alzheimer's patients receiving anti-dementia drugs in at-home care.
    PLoS One. 2020;15:e0231226.
    PubMed     Abstract available


  19. RHODIUS-MEESTER HFM, van Maurik IS, Koikkalainen J, Tolonen A, et al
    Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy.
    PLoS One. 2020;15:e0226784.
    PubMed     Abstract available


  20. CASTOR KJ, Shenoi S, Edminster SP, Tran T, et al
    Urine dicarboxylic acids change in pre-symptomatic Alzheimer's disease and reflect loss of energy capacity and hippocampal volume.
    PLoS One. 2020;15:e0231765.
    PubMed     Abstract available


  21. MOLINA M, Carmona I, Fuentes LJ, Plaza V, et al
    Enhanced learning and retention of medical information in Alzheimer's disease after differential outcomes training.
    PLoS One. 2020;15:e0231578.
    PubMed     Abstract available


  22. KANG MW, Park S, Lee S, Lee Y, et al
    Glomerular hyperfiltration is associated with dementia: A nationwide population-based study.
    PLoS One. 2020;15:e0228361.
    PubMed     Abstract available


  23. BURES J, Kvetina J, Radochova V, Tacheci I, et al
    The pharmacokinetic parameters and the effect of a single and repeated doses of memantine on gastric myoelectric activity in experimental pigs.
    PLoS One. 2020;15:e0227781.
    PubMed     Abstract available


  24. LIMBAD C, Oron TR, Alimirah F, Davalos AR, et al
    Astrocyte senescence promotes glutamate toxicity in cortical neurons.
    PLoS One. 2020;15:e0227887.
    PubMed     Abstract available


  25. ROMERO-ROSALES BL, Tamez-Pena JG, Nicolini H, Moreno-Trevino MG, et al
    Improving predictive models for Alzheimer's disease using GWAS data by incorporating misclassified samples modeling.
    PLoS One. 2020;15:e0232103.
    PubMed     Abstract available


  26. MUELLER KD, Norton D, Koscik RL, Morris MC, et al
    Self-reported health behaviors and longitudinal cognitive performance in late middle age: Results from the Wisconsin Registry for Alzheimer's Prevention.
    PLoS One. 2020;15:e0221985.
    PubMed     Abstract available


  27. BEACH TG, Adler CH, Zhang N, Serrano GE, et al
    Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia.
    PLoS One. 2020;15:e0231720.
    PubMed     Abstract available


  28. KIM JO, Lee SJ, Pyo JS
    Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: A meta-analysis.
    PLoS One. 2020;15:e0227820.
    PubMed     Abstract available


  29. ICHINOSE T, Murasawa H, Ishijima T, Okada S, et al
    Tyr-Trp administration facilitates brain norepinephrine metabolism and ameliorates a short-term memory deficit in a mouse model of Alzheimer's disease.
    PLoS One. 2020;15:e0232233.
    PubMed     Abstract available


  30. LARGENT EA, Harkins K, van Dyck CH, Hachey S, et al
    Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.
    PLoS One. 2020;15:e0229137.
    PubMed     Abstract available


  31. HIN N, Newman M, Kaslin J, Douek AM, et al
    Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2.
    PLoS One. 2020;15:e0227258.
    PubMed     Abstract available


  32. SOTO-MERCADO V, Mendivil-Perez M, Velez-Pardo C, Lopera F, et al
    Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPbeta fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications.
    PLoS One. 2020;15:e0221669.
    PubMed     Abstract available


  33. TSAI CW, Tsai CF, Lin KH, Chen WJ, et al
    An investigation of the correlation between the S-glutathionylated GAPDH levels in blood and Alzheimer's disease progression.
    PLoS One. 2020;15:e0233289.
    PubMed     Abstract available


  34. SEKINE T, Buck A, Delso G, Kemp B, et al
    The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data.
    PLoS One. 2020;15:e0233886.
    PubMed     Abstract available


  35. PINEDA AM, Ramos FM, Betting LE, Campanharo ASLO, et al
    Quantile graphs for EEG-based diagnosis of Alzheimer's disease.
    PLoS One. 2020;15:e0231169.
    PubMed     Abstract available


  36. JONESCO DS, Karsdal MA, Henriksen K
    The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional study.
    PLoS One. 2020;15:e0234632.
    PubMed     Abstract available


  37. XIE L, Varathan P, Nho K, Saykin AJ, et al
    Identification of functionally connected multi-omic biomarkers for Alzheimer's disease using modularity-constrained Lasso.
    PLoS One. 2020;15:e0234748.
    PubMed     Abstract available


  38. KIM B, Shin J, Kim Y, Choi JH, et al
    Destruction of ERP responses to deviance in an auditory oddball paradigm in amyloid infusion mice with memory deficits.
    PLoS One. 2020;15:e0230277.
    PubMed     Abstract available


    January 2019
  39. HUYNH MB, Ouidja MO, Chantepie S, Carpentier G, et al
    Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau.
    PLoS One. 2019;14:e0209573.
    PubMed     Abstract available


  40. HOLLNAGEL JO, Elzoheiry S, Gorgas K, Kins S, et al
    Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis.
    PLoS One. 2019;14:e0209228.
    PubMed     Abstract available


  41. PERETTI DE, Vallez Garcia D, Reesink FE, van der Goot T, et al
    Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.
    PLoS One. 2019;14:e0211000.
    PubMed     Abstract available


  42. BO Z, Wan Y, Meng SS, Lin T, et al
    The temporal trend and distribution characteristics in mortality of Alzheimer's disease and other forms of dementia in China: Based on the National Mortality Surveillance System (NMS) from 2009 to 2015.
    PLoS One. 2019;14:e0210621.
    PubMed     Abstract available


  43. CIMLER R, Maresova P, Kuhnova J, Kuca K, et al
    Predictions of Alzheimer's disease treatment and care costs in European countries.
    PLoS One. 2019;14:e0210958.
    PubMed     Abstract available


  44. CHO YY, Kwon OH, Park MK, Kim TW, et al
    Elevated cellular cholesterol in Familial Alzheimer's presenilin 1 mutation is associated with lipid raft localization of beta-amyloid precursor protein.
    PLoS One. 2019;14:e0210535.
    PubMed     Abstract available


  45. WEINSTEIN G, Davis-Plourde KL, Conner S, Himali JJ, et al
    Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts.
    PLoS One. 2019;14:e0212293.
    PubMed     Abstract available


  46. BEGIC E, Hadzidedic S, Kulaglic A, Ramic-Brkic B, et al
    SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients.
    PLoS One. 2019;14:e0212261.
    PubMed     Abstract available


  47. MOORE PJ, Lyons TJ, Gallacher J
    Random forest prediction of Alzheimer's disease using pairwise selection from time series data.
    PLoS One. 2019;14:e0211558.
    PubMed     Abstract available


  48. NGUYEN DT, Ryu S, Qureshi MNI, Choi M, et al
    Hybrid multivariate pattern analysis combined with extreme learning machine for Alzheimer's dementia diagnosis using multi-measure rs-fMRI spatial patterns.
    PLoS One. 2019;14:e0212582.
    PubMed     Abstract available


  49. CAILLAUD M, Guillard J, Richard D, Milin S, et al
    Trans epsilon viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model.
    PLoS One. 2019;14:e0212663.
    PubMed     Abstract available


  50. JUNAID M, Islam N, Hossain MK, Ullah MO, et al
    Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.
    PLoS One. 2019;14:e0211935.
    PubMed     Abstract available


  51. MARTI-JUAN G, Sanroma G, Piella G
    Revealing heterogeneity of brain imaging phenotypes in Alzheimer's disease based on unsupervised clustering of blood marker profiles.
    PLoS One. 2019;14:e0211121.
    PubMed     Abstract available


  52. ORIMAYE SO, Wong JS, Wong CP
    Correction: Deep language space neural network for classifying mild cognitive impairment and Alzheimer-type dementia.
    PLoS One. 2019;14:e0214103.
    PubMed     Abstract available


  53. HAFT-JAVAHERIAN M, Fang L, Muse V, Schaffer CB, et al
    Deep convolutional neural networks for segmenting 3D in vivo multiphoton images of vasculature in Alzheimer disease mouse models.
    PLoS One. 2019;14:e0213539.
    PubMed     Abstract available


  54. KURIMOTO E, Nakashima M, Kimura H, Suzuki M, et al
    TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys.
    PLoS One. 2019;14:e0207969.
    PubMed     Abstract available


  55. PERETTI DE, Vallez Garcia D, Reesink FE, van der Goot T, et al
    Correction: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.
    PLoS One. 2019;14:e0214187.
    PubMed     Abstract available


  56. NOMOTO S, Kinno R, Ochiai H, Kubota S, et al
    The relationship between thyroid function and cerebral blood flow in mild cognitive impairment and Alzheimer's disease.
    PLoS One. 2019;14:e0214676.
    PubMed     Abstract available


  57. ZHANG YS, Zhou N, Knoll BM, Samra S, et al
    Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer's Disease on optical coherence tomography angiography.
    PLoS One. 2019;14:e0214685.
    PubMed     Abstract available


  58. KIM JE, Park JJ, Lee MR, Choi JY, et al
    Constipation in Tg2576 mice model for Alzheimer's disease associated with dysregulation of mechanism involving the mAChR signaling pathway and ER stress response.
    PLoS One. 2019;14:e0215205.
    PubMed     Abstract available


  59. ROBY DA, Ruiz F, Kermath BA, Voorhees JR, et al
    Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-beta burden in a mouse model of Alzheimer's disease.
    PLoS One. 2019;14:e0215004.
    PubMed     Abstract available


  60. SOOBIAH C, Tadrous M, Knowles S, Blondal E, et al
    Variability in the validity and reliability of outcome measures identified in a systematic review to assess treatment efficacy of cognitive enhancers for Alzheimer's Dementia.
    PLoS One. 2019;14:e0215225.
    PubMed     Abstract available


  61. WESTFALL S, Lomis N, Prakash S
    A novel synbiotic delays Alzheimer's disease onset via combinatorial gut-brain-axis signaling in Drosophila melanogaster.
    PLoS One. 2019;14:e0214985.
    PubMed     Abstract available


  62. BAILLY L, David R, Chevrier R, Grebet J, et al
    Alzheimer's disease: Estimating its prevalence rate in a French geographical unit using the National Alzheimer Data Bank and national health insurance information systems.
    PLoS One. 2019;14:e0216221.
    PubMed     Abstract available


  63. JOVIC M, Loncarevic-Vasiljkovic N, Ivkovic S, Dinic J, et al
    Short-term fish oil supplementation applied in presymptomatic stage of Alzheimer's disease enhances microglial/macrophage barrier and prevents neuritic dystrophy in parietal cortex of 5xFAD mouse model.
    PLoS One. 2019;14:e0216726.
    PubMed     Abstract available


  64. LAFIRDEEN ASM, Cognat E, Sabia S, Hourregue C, et al
    Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of beta-amyloid peptide and tau.
    PLoS One. 2019;14:e0217026.
    PubMed     Abstract available


  65. NUNES A, Silva G, Duque C, Januario C, et al
    Retinal texture biomarkers may help to discriminate between Alzheimer's, Parkinson's, and healthy controls.
    PLoS One. 2019;14:e0218826.
    PubMed     Abstract available


  66. SCHULTZ N, Janelidze S, Byman E, Minthon L, et al
    Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer's disease.
    PLoS One. 2019;14:e0218561.
    PubMed     Abstract available


  67. MALEK-AHMADI M, Beach TG, Zamrini E, Adler CH, et al
    Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.
    PLoS One. 2019;14:e0217566.
    PubMed     Abstract available


  68. SONG YQ, Li Y, Zhang SL, Gao J, et al
    Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients.
    PLoS One. 2019;14:e0219213.
    PubMed     Abstract available


  69. GODINI R, Pocock R, Fallahi H
    Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer's disease.
    PLoS One. 2019;14:e0219486.
    PubMed     Abstract available


  70. BAKER E, Sims R, Leonenko G, Frizzati A, et al
    Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.
    PLoS One. 2019;14:e0218111.
    PubMed     Abstract available


  71. LEE JS, Lee Y, Andre EA, Lee KJ, et al
    Inhibition of Polo-like kinase 2 ameliorates pathogenesis in Alzheimer's disease model mice.
    PLoS One. 2019;14:e0219691.
    PubMed     Abstract available


  72. ROCHOY M, Bordet R, Gautier S, Chazard E, et al
    Factors associated with the onset of Alzheimer's disease: Data mining in the French nationwide discharge summary database between 2008 and 2014.
    PLoS One. 2019;14:e0220174.
    PubMed     Abstract available


  73. CHOI M, Youn H, Kim D, Lee S, et al
    Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    PLoS One. 2019;14:e0220739.
    PubMed     Abstract available


  74. ERTUZUN T, Semerci A, Cakir ME, Ekmekcioglu A, et al
    Investigation of base excision repair gene variants in late-onset Alzheimer's disease.
    PLoS One. 2019;14:e0221362.
    PubMed     Abstract available


  75. SALOBRAR-GARCIA E, de Hoz R, Ramirez AI, Lopez-Cuenca I, et al
    Changes in visual function and retinal structure in the progression of Alzheimer's disease.
    PLoS One. 2019;14:e0220535.
    PubMed     Abstract available


  76. PICARD C, Poirier A, Belanger S, Labonte A, et al
    Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study.
    PLoS One. 2019;14:e0220254.
    PubMed     Abstract available


  77. MULLER EG, Edwin TH, Stokke C, Navelsaker SS, et al
    Amyloid-beta PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer s disease diagnosis in a memory clinic.
    PLoS One. 2019;14:e0221365.
    PubMed     Abstract available


  78. PRZYBYLSKA-KUC S, Zakrzewski M, Dybala A, Kicinski P, et al
    Obstructive sleep apnea may increase the risk of Alzheimer's disease.
    PLoS One. 2019;14:e0221255.
    PubMed     Abstract available


  79. MOREIRA HS, Costa AS, Machado A, Castro SL, et al
    Distinguishing mild cognitive impairment from healthy aging and Alzheimer's Disease: The contribution of the INECO Frontal Screening (IFS).
    PLoS One. 2019;14:e0221873.
    PubMed     Abstract available


  80. MOORE PJ, Lyons TJ, Gallacher J
    Using path signatures to predict a diagnosis of Alzheimer's disease.
    PLoS One. 2019;14:e0222212.
    PubMed     Abstract available


  81. BENITO-LEON J, Contador I, Vega S, Villarejo-Galende A, et al
    Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality.
    PLoS One. 2019;14:e0222505.
    PubMed     Abstract available



  82. Correction: Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    PLoS One. 2019;14:e0222852.
    PubMed     Abstract available


  83. POTASHKIN JA, Bottero V, Santiago JA, Quinn JP, et al
    Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer's patients.
    PLoS One. 2019;14:e0222921.
    PubMed     Abstract available


  84. LIU Z, Wang W, Huang T, Wang C, et al
    CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer's disease.
    PLoS One. 2019;14:e0222757.
    PubMed     Abstract available


  85. GILLIGAN TM, Sibilia F, Farrell D, Lyons D, et al
    No relationship between fornix and cingulum degradation and within-network decreases in functional connectivity in prodromal Alzheimer's disease.
    PLoS One. 2019;14:e0222977.
    PubMed     Abstract available


  86. SMILNAK GJ, Deans JR, Doraiswamy PM, Stinnett S, et al
    Comorbidity of age-related macular degeneration with Alzheimer's disease: A histopathologic case-control study.
    PLoS One. 2019;14:e0223199.
    PubMed     Abstract available


  87. JOSEPH DJ, Liu C, Peng J, Liang G, et al
    Isoflurane mediated neuropathological and cognitive impairments in the triple transgenic Alzheimer's mouse model are associated with hippocampal synaptic deficits in an age-dependent manner.
    PLoS One. 2019;14:e0223509.
    PubMed     Abstract available


  88. SUDO FK, de Souza AS, Drummond C, Assuncao N, et al
    Inter-method and anatomical correlates of episodic memory tests in the Alzheimer's Disease spectrum.
    PLoS One. 2019;14:e0223731.
    PubMed     Abstract available


  89. MUNOZ-CABRERA JM, Sandoval-Hernandez AG, Nino A, Baez T, et al
    Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer s disease.
    PLoS One. 2019;14:e0223578.
    PubMed     Abstract available


  90. GUPTA Y, Lee KH, Choi KY, Lee JJ, et al
    Early diagnosis of Alzheimer's disease using combined features from voxel-based morphometry and cortical, subcortical, and hippocampus regions of MRI T1 brain images.
    PLoS One. 2019;14:e0222446.
    PubMed     Abstract available


  91. PARKER TD, Cash DM, Lane CAS, Lu K, et al
    Hippocampal subfield volumes and pre-clinical Alzheimer's disease in 408 cognitively normal adults born in 1946.
    PLoS One. 2019;14:e0224030.
    PubMed     Abstract available


  92. JANG HD, Park JS, Kim DW, Han K, et al
    Relationship between dementia and ankylosing spondylitis: A nationwide, population-based, retrospective longitudinal cohort study.
    PLoS One. 2019;14:e0210335.
    PubMed     Abstract available


  93. GOFRIT ON, Klein BY, Cohen IR, Ben-Hur T, et al
    Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
    PLoS One. 2019;14:e0224433.
    PubMed     Abstract available


  94. YOUSSIF KA, Haggag EG, Elshamy AM, Rabeh MA, et al
    Anti-Alzheimer potential, metabolomic profiling and molecular docking of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea aqueous extracts.
    PLoS One. 2019;14:e0223781.
    PubMed     Abstract available


  95. KIM JI, Kang BH
    Decreased retinal thickness in patients with Alzheimer's disease is correlated with disease severity.
    PLoS One. 2019;14:e0224180.
    PubMed     Abstract available


  96. DEMARSHALL C, Oh E, Kheirkhah R, Sieber F, et al
    Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients.
    PLoS One. 2019;14:e0225178.
    PubMed     Abstract available


  97. YANEZ LOPEZ M, Pardon MC, Baiker K, Prior M, et al
    Myoinositol CEST signal in animals with increased Iba-1 levels in response to an inflammatory challenge-Preliminary findings.
    PLoS One. 2019;14:e0212002.
    PubMed     Abstract available


  98. HUANG Q, Sun D, Zubair Hussain M, Liu Y, et al
    HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity.
    PLoS One. 2019;14:e0212648.
    PubMed     Abstract available


  99. CHO SJ, Yun SM, Jo C, Jeong J, et al
    Altered expression of Notch1 in Alzheimer's disease.
    PLoS One. 2019;14:e0224941.
    PubMed     Abstract available


  100. PANAYIOTOU E, Fella E, Andreou S, Papacharalambous R, et al
    C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Abeta amyloid and preserves memory in a mouse model of familial Alzheimer's disease.
    PLoS One. 2019;14:e0225417.
    PubMed     Abstract available


  101. PUNJABI A, Martersteck A, Wang Y, Parrish TB, et al
    Neuroimaging modality fusion in Alzheimer's classification using convolutional neural networks.
    PLoS One. 2019;14:e0225759.
    PubMed     Abstract available


  102. SILZER T, Barber R, Sun J, Pathak G, et al
    Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans.
    PLoS One. 2019;14:e0213527.
    PubMed     Abstract available


  103. PARK JE, Yun J, Kim SJ, Shim WH, et al
    Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity.
    PLoS One. 2019;14:e0226265.
    PubMed     Abstract available


  104. OH AJ, Amore G, Sultan W, Asanad S, et al
    Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer's disease.
    PLoS One. 2019;14:e0226197.
    PubMed     Abstract available


  105. TOKUOKA SM, Kita Y, Shimizu T, Oda Y, et al
    Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease.
    PLoS One. 2019;14:e0226073.
    PubMed     Abstract available


  106. ELMER BM, Swanson KA, Bangari DS, Piepenhagen PA, et al
    Gene delivery of a modified antibody to Abeta reduces progression of murine Alzheimer's disease.
    PLoS One. 2019;14:e0226245.
    PubMed     Abstract available


  107. OZSAHIN I, Sekeroglu B, Mok GSP
    The use of back propagation neural networks and 18F-Florbetapir PET for early detection of Alzheimer's disease using Alzheimer's Disease Neuroimaging Initiative database.
    PLoS One. 2019;14:e0226577.
    PubMed     Abstract available


  108. IVASHKO-PACHIMA Y, Maor-Nof M, Gozes I
    NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
    PLoS One. 2019;14:e0213666.
    PubMed     Abstract available


  109. MCGRATH ER, Himali JJ, Levy D, Conner SC, et al
    Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.
    PLoS One. 2019;14:e0213321.
    PubMed     Abstract available


  110. GRANT MKO, Handoko M, Rozga M, Brinkmalm G, et al
    Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments.
    PLoS One. 2019;14:e0212815.
    PubMed     Abstract available


  111. DING X, Charnigo RJ, Schmitt FA, Kryscio RJ, et al
    Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI.
    PLoS One. 2019;14:e0212435.
    PubMed     Abstract available


  112. MONACO A, Amoroso N, Bellantuono L, Lella E, et al
    Shannon entropy approach reveals relevant genes in Alzheimer's disease.
    PLoS One. 2019;14:e0226190.
    PubMed     Abstract available


  113. ROYALL DR, Palmer RF
    Selection for depression-specific dementia cases with replication in two cohorts.
    PLoS One. 2019;14:e0216413.
    PubMed     Abstract available


  114. PATIL DN, Patil SA, Sistla S, Jadhav JP, et al
    Comparative biophysical characterization: A screening tool for acetylcholinesterase inhibitors.
    PLoS One. 2019;14:e0215291.
    PubMed     Abstract available


  115. ESQUERDA-CANALS G, Marti-Clua J, Villegas S
    Pharmacokinetic parameters and mechanism of action of an efficient anti-Abeta single chain antibody fragment.
    PLoS One. 2019;14:e0217793.
    PubMed     Abstract available


  116. SINNIGE T, Ciryam P, Casford S, Dobson CM, et al
    Expression of the amyloid-beta peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response.
    PLoS One. 2019;14:e0217746.
    PubMed     Abstract available


  117. HUANG YY, Chiu MJ, Yen RF, Tsai CL, et al
    An one-pot two-step automated synthesis of [18F]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans.
    PLoS One. 2019;14:e0217384.
    PubMed     Abstract available


  118. ETO M, Hashimoto T, Shimizu T, Iwatsubo T, et al
    Characterization of the unique In Vitro effects of unsaturated fatty acids on the formation of amyloid beta fibrils.
    PLoS One. 2019;14:e0219465.
    PubMed     Abstract available


  119. CHEN JL, Moss WN, Spencer A, Zhang P, et al
    The RNA encoding the microtubule-associated protein tau has extensive structure that affects its biology.
    PLoS One. 2019;14:e0219210.
    PubMed     Abstract available


  120. HUANG CN, Wang CJ, Lin CL, Yen AT, et al
    Abelmoschus esculentus subfractions attenuate beta amyloid-induced neuron apoptosis by regulating DPP-4 with improving insulin resistance signals.
    PLoS One. 2019;14:e0217400.
    PubMed     Abstract available


  121. HOFFMAN JD, Yanckello LM, Chlipala G, Hammond TC, et al
    Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model.
    PLoS One. 2019;14:e0221828.
    PubMed     Abstract available


  122. MCAVOY KM, Rajamohamed Sait H, Marsh G, Peterson M, et al
    Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.
    PLoS One. 2019;14:e0220125.
    PubMed     Abstract available


  123. BUCHMAN AS, Yu L, Petyuk VA, Gaiteri C, et al
    Cognition may link cortical IGFBP5 levels with motor function in older adults.
    PLoS One. 2019;14:e0220968.
    PubMed     Abstract available


  124. HVIDSTEN L, Engedal K, Selbaek G, Wyller TB, et al
    Quality of life of family carers of persons with young-onset dementia: A Nordic two-year observational multicenter study.
    PLoS One. 2019;14:e0219859.
    PubMed     Abstract available


  125. UEKI M, Fujii M, Tamiya G
    Quick assessment for systematic test statistic inflation/deflation due to null model misspecifications in genome-wide environment interaction studies.
    PLoS One. 2019;14:e0219825.
    PubMed     Abstract available


  126. REES JMB, Wood AM, Dudbridge F, Burgess S, et al
    Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates.
    PLoS One. 2019;14:e0222362.
    PubMed     Abstract available


  127. CHAGANTI S, Welty VF, Taylor W, Albert K, et al
    Discovering novel disease comorbidities using electronic medical records.
    PLoS One. 2019;14:e0225495.
    PubMed     Abstract available


    January 2018
  128. DO K, Laing BT, Landry T, Bunner W, et al
    The effects of exercise on hypothalamic neurodegeneration of Alzheimer's disease mouse model.
    PLoS One. 2018;13:e0190205.
    PubMed     Abstract available


  129. MASTROENI D, Sekar S, Nolz J, Delvaux E, et al
    Correction: ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.
    PLoS One. 2018;13:e0191382.
    PubMed     Abstract available


  130. HAIGHT T, Bryan RN, Meirelles O, Tracy R, et al
    Associations of plasma clusterin and Alzheimer's disease-related MRI markers in adults at mid-life: The CARDIA Brain MRI sub-study.
    PLoS One. 2018;13:e0190478.
    PubMed     Abstract available


  131. HADJICHRYSANTHOU C, Ower AK, de Wolf F, Anderson RM, et al
    The development of a stochastic mathematical model of Alzheimer's disease to help improve the design of clinical trials of potential treatments.
    PLoS One. 2018;13:e0190615.
    PubMed     Abstract available


  132. LAD EM, Mukherjee D, Stinnett SS, Cousins SW, et al
    Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease.
    PLoS One. 2018;13:e0192646.
    PubMed     Abstract available


  133. DE LEON MJ, Pirraglia E, Osorio RS, Glodzik L, et al
    The nonlinear relationship between cerebrospinal fluid Abeta42 and tau in preclinical Alzheimer's disease.
    PLoS One. 2018;13:e0191240.
    PubMed     Abstract available


  134. YOU JC, Stephens GS, Fu CH, Zhang X, et al
    Genome-wide profiling reveals functional diversification of FosB gene targets in the hippocampus of an Alzheimer's disease mouse model.
    PLoS One. 2018;13:e0192508.
    PubMed     Abstract available


  135. JIANG H, Liu Y, Wei Y, Shi Y, et al
    Impaired retinal microcirculation in patients with Alzheimer's disease.
    PLoS One. 2018;13:e0192154.
    PubMed     Abstract available


  136. MOSCONI L, Berti V, Quinn C, McHugh P, et al
    Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
    PLoS One. 2018;13:e0193314.
    PubMed     Abstract available


  137. TROMBETTA BA, Carlyle BC, Koenig AM, Shaw LM, et al
    The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.
    PLoS One. 2018;13:e0193707.
    PubMed     Abstract available


  138. VAN GIJSEL-BONNELLO M, Baranger K, Benech P, Rivera S, et al
    Correction: Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.
    PLoS One. 2018;13:e0194586.
    PubMed     Abstract available


  139. HOUMANI N, Vialatte F, Gallego-Jutgla E, Dreyfus G, et al
    Diagnosis of Alzheimer's disease with Electroencephalography in a differential framework.
    PLoS One. 2018;13:e0193607.
    PubMed     Abstract available


  140. WHITE MR, Kandel R, Hsieh IN, De Luna X, et al
    Critical role of C-terminal residues of the Alzheimer's associated beta-amyloid protein in mediating antiviral activity and modulating viral and bacterial interactions with neutrophils.
    PLoS One. 2018;13:e0194001.
    PubMed     Abstract available


  141. BI XA, Shu Q, Sun Q, Xu Q, et al
    Random support vector machine cluster analysis of resting-state fMRI in Alzheimer's disease.
    PLoS One. 2018;13:e0194479.
    PubMed     Abstract available


  142. KLAKOTSKAIA D, Agca C, Richardson RA, Stopa EG, et al
    Memory deficiency, cerebral amyloid angiopathy, and amyloid-beta plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
    PLoS One. 2018;13:e0195469.
    PubMed     Abstract available


  143. STEPANOV A, Karelina T, Markevich N, Demin O, et al
    A mathematical model of multisite phosphorylation of tau protein.
    PLoS One. 2018;13:e0192519.
    PubMed     Abstract available


  144. BARRERA J, Subramanian S, Chiba-Falek O
    Probing the role of PPARgamma in the regulation of late-onset Alzheimer's disease-associated genes.
    PLoS One. 2018;13:e0196943.
    PubMed     Abstract available


  145. DENK J, Oberhauser F, Kornhuber J, Wiltfang J, et al
    Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls.
    PLoS One. 2018;13:e0197329.
    PubMed     Abstract available


  146. SALAMA M, Shalash A, Magdy A, Makar M, et al
    Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases.
    PLoS One. 2018;13:e0196436.
    PubMed     Abstract available


  147. LEE S, Zimmerman ME, Narkhede A, Nasrabady SE, et al
    White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease.
    PLoS One. 2018;13:e0195838.
    PubMed     Abstract available


  148. HIGAKI S, Muramatsu M, Matsuda A, Matsumoto K, et al
    Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models.
    PLoS One. 2018;13:e0196929.
    PubMed     Abstract available


  149. ZHENG W, Su Z, Liu X, Zhang H, et al
    Modulation of functional activity and connectivity by acupuncture in patients with Alzheimer disease as measured by resting-state fMRI.
    PLoS One. 2018;13:e0196933.
    PubMed     Abstract available


  150. ULBRICH S, Janning P, Seidel R, Matschke J, et al
    Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.
    PLoS One. 2018;13:e0197659.
    PubMed     Abstract available


  151. MATSUSHITA M, Yatabe Y, Koyama A, Katsuya A, et al
    Are saving appearance responses typical communication patterns in Alzheimer's disease?
    PLoS One. 2018;13:e0197468.
    PubMed     Abstract available


  152. LASHKARI K, Teague G, Chen H, Lin YQ, et al
    A monoclonal antibody targeting amyloid beta (Abeta) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease.
    PLoS One. 2018;13:e0195751.
    PubMed     Abstract available


  153. KOBAYASHI Y, Inagawa H, Kohchi C, Kazumura K, et al
    Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents metabolic dysfunction and Alzheimer's disease-related memory loss in senescence-accelerated prone 8 (SAMP8) mice fed a high-fat diet.
    PLoS One. 2018;13:e0198493.
    PubMed     Abstract available


  154. NYITRAI G, Spisak T, Spisak Z, Gajari D, et al
    Stepwise occlusion of the carotid arteries of the rat: MRI assessment of the effect of donepezil and hypoperfusion-induced brain atrophy and white matter microstructural changes.
    PLoS One. 2018;13:e0198265.
    PubMed     Abstract available


  155. MARSHALL MS, Jakubauskas B, Bogue W, Stoskute M, et al
    Analysis of age-related changes in psychosine metabolism in the human brain.
    PLoS One. 2018;13:e0193438.
    PubMed     Abstract available


  156. ZHANG Y, Lin C, Zhang L, Cui Y, et al
    Correction: Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial.
    PLoS One. 2018;13:e0199895.
    PubMed     Abstract available


  157. WOOD PL, Tippireddy S, Feriante J, Woltjer RL, et al
    Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease.
    PLoS One. 2018;13:e0191815.
    PubMed     Abstract available


  158. GOTZ A, Scharnagl C
    Dissecting conformational changes in APP's transmembrane domain linked to epsilon-efficiency in familial Alzheimer's disease.
    PLoS One. 2018;13:e0200077.
    PubMed     Abstract available


  159. HANE F, Augusta C, Bai O
    A hierarchical Bayesian model to predict APOE4 genotype and the age of Alzheimer's disease onset.
    PLoS One. 2018;13:e0200263.
    PubMed     Abstract available


  160. ESPARZA TJ, Gangolli M, Cairns NJ, Brody DL, et al
    Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls.
    PLoS One. 2018;13:e0200251.
    PubMed     Abstract available


  161. TISATO V, Zuliani G, Vigliano M, Longo G, et al
    Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.
    PLoS One. 2018;13:e0193867.
    PubMed     Abstract available


  162. DERKOW K, Rossling R, Schipke C, Kruger C, et al
    Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's disease.
    PLoS One. 2018;13:e0200602.
    PubMed     Abstract available


  163. CROFT CL, Moore BD, Ran Y, Chakrabarty P, et al
    Novel monoclonal antibodies targeting the microtubule-binding domain of human tau.
    PLoS One. 2018;13:e0195211.
    PubMed     Abstract available


  164. NEERGAARD JS, Dragsbaek K, Christiansen C, Karsdal MA, et al
    Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.
    PLoS One. 2018;13:e0194802.
    PubMed     Abstract available


  165. VERITE J, Page G, Paccalin M, Julian A, et al
    Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model.
    PLoS One. 2018;13:e0201232.
    PubMed     Abstract available


  166. DAYEH MA, Livadiotis G, Elaydi S
    A discrete mathematical model for the aggregation of beta-Amyloid.
    PLoS One. 2018;13:e0196402.
    PubMed     Abstract available


  167. MAAROUF CL, Walker JE, Sue LI, Dugger BN, et al
    Impaired hepatic amyloid-beta degradation in Alzheimer's disease.
    PLoS One. 2018;13:e0203659.
    PubMed     Abstract available


  168. FUROTANI K, Kamimura K, Yajima T, Nakayama M, et al
    Suppression of the synaptic localization of a subset of proteins including APP partially ameliorates phenotypes of the Drosophila Alzheimer's disease model.
    PLoS One. 2018;13:e0204048.
    PubMed     Abstract available


  169. HOARAU M, Malbert Y, Irague R, Hureau C, et al
    Correction: A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-beta Peptides.
    PLoS One. 2018;13:e0205048.
    PubMed     Abstract available


  170. LEE J, Jung SJ, Choi JW, Shin A, et al
    Use of sedative-hypnotics and the risk of Alzheimer's dementia: A retrospective cohort study.
    PLoS One. 2018;13:e0204413.
    PubMed     Abstract available


  171. DONG X, Yan L, Huang L, Guan X, et al
    Repetitive transcranial magnetic stimulation for the treatment of Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2018;13:e0205704.
    PubMed     Abstract available



  172. Correction: Use of sedative-hypnotics and the risk of Alzheimer's dementia: A retrospective cohort study.
    PLoS One. 2018;13:e0206094.
    PubMed     Abstract available


  173. JIANG H, Newman M, Lardelli M
    The zebrafish orthologue of familial Alzheimer's disease gene PRESENILIN 2 is required for normal adult melanotic skin pigmentation.
    PLoS One. 2018;13:e0206155.
    PubMed     Abstract available


  174. ROCHON PA, Gruneir A, Bell CM, Savage R, et al
    Comparison of prescribing practices for older adults treated by female versus male physicians: A retrospective cohort study.
    PLoS One. 2018;13:e0205524.
    PubMed     Abstract available


  175. BARTHOLD D, Joyce G, Wharton W, Kehoe P, et al
    The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicity.
    PLoS One. 2018;13:e0206705.
    PubMed     Abstract available


  176. KATSEL P, Roussos P, Beeri MS, Gama-Sosa MA, et al
    Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer's disease and normalized by treatment with anti-diabetic agents.
    PLoS One. 2018;13:e0206547.
    PubMed     Abstract available


  177. ORIMAYE SO, Wong JS, Wong CP
    Deep language space neural network for classifying mild cognitive impairment and Alzheimer-type dementia.
    PLoS One. 2018;13:e0205636.
    PubMed     Abstract available


  178. OGAWA M, Sone D, Maruo K, Shimada H, et al
    Analysis of risk factors for mild cognitive impairment based on word list memory test results and questionnaire responses in healthy Japanese individuals registered in an online database.
    PLoS One. 2018;13:e0197466.
    PubMed     Abstract available


  179. MOSCONI L, Rahman A, Diaz I, Wu X, et al
    Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.
    PLoS One. 2018;13:e0207885.
    PubMed     Abstract available


  180. WATTS AS, Mortby ME, Burns JM
    Depressive symptoms as a barrier to engagement in physical activity in older adults with and without Alzheimer's disease.
    PLoS One. 2018;13:e0208581.
    PubMed     Abstract available


  181. HAGENAARS SP, Radakovic R, Crockford C, Fawns-Ritchie C, et al
    Genetic risk for neurodegenerative disorders, and its overlap with cognitive ability and physical function.
    PLoS One. 2018;13:e0198187.
    PubMed     Abstract available


  182. STUDNICKI M, Wozniak G, Stepkowski D
    Correction: The Calculator of Anti-Alzheimer's Diet. Macronutrients.
    PLoS One. 2018;13:e0209723.
    PubMed     Abstract available


  183. PAVONI S, Jarray R, Nassor F, Guyot AC, et al
    Small-molecule induction of Abeta-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
    PLoS One. 2018;13:e0209150.
    PubMed     Abstract available


  184. CESPEDES MI, McGree J, Drovandi CC, Mengersen K, et al
    An efficient algorithm for estimating brain covariance networks.
    PLoS One. 2018;13:e0198583.
    PubMed     Abstract available


  185. ANDARZI GARGARI S, Barzegar A, Tarinejad A
    The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing beta-sheet conformation of monomeric Abeta17-42.
    PLoS One. 2018;13:e0199541.
    PubMed     Abstract available


  186. SATO S, Ueki M
    Fast score test with global null estimation regardless of missing genotypes.
    PLoS One. 2018;13:e0199692.
    PubMed     Abstract available


  187. EVANS S, Clarke D, Dowell NG, Tabet N, et al
    Using event-related fMRI to examine sustained attention processes and effects of APOE epsilon4 in young adults.
    PLoS One. 2018;13:e0198312.
    PubMed     Abstract available


  188. TAKASUGI N, Araya R, Kamikubo Y, Kaneshiro N, et al
    TMEM30A is a candidate interacting partner for the beta-carboxyl-terminal fragment of amyloid-beta precursor protein in endosomes.
    PLoS One. 2018;13:e0200988.
    PubMed     Abstract available


  189. LATULIPPE J, Lotito D, Murby D
    A mathematical model for the effects of amyloid beta on intracellular calcium.
    PLoS One. 2018;13:e0202503.
    PubMed     Abstract available


  190. LOBACH I, Sampson J, Alekseyenko A, Lobach S, et al
    Case-control studies of gene-environment interactions. When a case might not be the case.
    PLoS One. 2018;13:e0201140.
    PubMed     Abstract available


  191. JANG JW, Park JH, Kim S, Park YH, et al
    A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment.
    PLoS One. 2018;13:e0201852.
    PubMed     Abstract available


  192. MARINO S, Xu J, Zhao Y, Zhou N, et al
    Controlled feature selection and compressive big data analytics: Applications to biomedical and health studies.
    PLoS One. 2018;13:e0202674.
    PubMed     Abstract available


  193. OH ES, Blennow K, Bigelow GE, Inouye SK, et al
    Abnormal CSF amyloid-beta42 and tau levels in hip fracture patients without dementia.
    PLoS One. 2018;13:e0204695.
    PubMed     Abstract available


  194. ILIEVSKI V, Zuchowska PK, Green SJ, Toth PT, et al
    Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice.
    PLoS One. 2018;13:e0204941.
    PubMed     Abstract available


  195. DIEM AK, Carare RO, Weller RO, Bressloff NW, et al
    A control mechanism for intra-mural peri-arterial drainage via astrocytes: How neuronal activity could improve waste clearance from the brain.
    PLoS One. 2018;13:e0205276.
    PubMed     Abstract available


  196. BALLARINI NM, Rosenkranz GK, Jaki T, Konig F, et al
    Subgroup identification in clinical trials via the predicted individual treatment effect.
    PLoS One. 2018;13:e0205971.
    PubMed     Abstract available


  197. LIN W, Xie YC, Cheng PY, Dong LY, et al
    Association of visual hallucinations with very mild degenerative dementia due to dementia with Lewy bodies.
    PLoS One. 2018;13:e0205909.
    PubMed     Abstract available


  198. SIDDARTH P, Burggren AC, Merrill DA, Ercoli LM, et al
    Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.
    PLoS One. 2018;13:e0208358.
    PubMed     Abstract available


    January 2017
  199. GAVIDIA-BOVADILLA G, Kanaan-Izquierdo S, Mataro-Serrat M, Perera-Lluna A, et al
    Early Prediction of Alzheimer's Disease Using Null Longitudinal Model-Based Classifiers.
    PLoS One. 2017;12:e0168011.
    PubMed     Abstract available


  200. PAPAZOGLOU A, Soos J, Lundt A, Wormuth C, et al
    Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice.
    PLoS One. 2017;12:e0169654.
    PubMed     Abstract available


  201. SONG Y, Kim HD, Lee MK, Hong IH, et al
    Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    PLoS One. 2017;12:e0169509.
    PubMed     Abstract available


  202. LI Y, Li Y, Li X, Zhang S, et al
    Head Injury as a Risk Factor for Dementia and Alzheimer's Disease: A Systematic Review and Meta-Analysis of 32 Observational Studies.
    PLoS One. 2017;12:e0169650.
    PubMed     Abstract available


  203. PAN X, Sang S, Fei G, Jin L, et al
    Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer's Disease.
    PLoS One. 2017;12:e0167273.
    PubMed     Abstract available


  204. MELLOTT TJ, Huleatt OM, Shade BN, Pender SM, et al
    Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
    PLoS One. 2017;12:e0170450.
    PubMed     Abstract available


  205. CAI K, Xu H, Guan H, Zhu W, et al
    Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices.
    PLoS One. 2017;12:e0170875.
    PubMed     Abstract available


  206. KASTANENKA KV, Hou SS, Shakerdge N, Logan R, et al
    Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease.
    PLoS One. 2017;12:e0170275.
    PubMed     Abstract available


  207. MORIMOTO S, Takao M, Hatsuta H, Nishina Y, et al
    Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
    PLoS One. 2017;12:e0171524.
    PubMed     Abstract available


  208. MIN LJ, Kobayashi Y, Mogi M, Tsukuda K, et al
    Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice.
    PLoS One. 2017;12:e0171515.
    PubMed     Abstract available


  209. COVA I, Pomati S, Maggiore L, Forcella M, et al
    Nutritional status and body composition by bioelectrical impedance vector analysis: A cross sectional study in mild cognitive impairment and Alzheimer's disease.
    PLoS One. 2017;12:e0171331.
    PubMed     Abstract available


  210. MORRIS JK, Vidoni ED, Johnson DK, Van Sciver A, et al
    Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial.
    PLoS One. 2017;12:e0170547.
    PubMed     Abstract available


  211. XU W, Liu J, Ma D, Yuan G, et al
    Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
    PLoS One. 2017;12:e0172477.
    PubMed     Abstract available


  212. SCHMIDT SA, Ording AG, Horvath-Puho E, Sorensen HT, et al
    Non-melanoma skin cancer and risk of Alzheimer's disease and all-cause dementia.
    PLoS One. 2017;12:e0171527.
    PubMed     Abstract available


  213. OGAMA N, Sakurai T, Nakai T, Niida S, et al
    Impact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment.
    PLoS One. 2017;12:e0172484.
    PubMed     Abstract available


  214. JI H, Wang Y, Liu G, Chang L, et al
    Elevated OPRD1 promoter methylation in Alzheimer's disease patients.
    PLoS One. 2017;12:e0172335.
    PubMed     Abstract available


  215. TOLPPANEN AM, Voutilainen A, Taipale H, Tanskanen A, et al
    Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011.
    PLoS One. 2017;12:e0173450.
    PubMed     Abstract available


  216. LONG X, Chen L, Jiang C, Zhang L, et al
    Prediction and classification of Alzheimer disease based on quantification of MRI deformation.
    PLoS One. 2017;12:e0173372.
    PubMed     Abstract available


  217. HOY AR, Ly M, Carlsson CM, Okonkwo OC, et al
    Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging.
    PLoS One. 2017;12:e0173982.
    PubMed     Abstract available


  218. MELLOTT TJ, Huleatt OM, Shade BN, Pender SM, et al
    Correction: Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
    PLoS One. 2017;12:e0174875.
    PubMed     Abstract available


  219. SON SJ, Kim J, Park H
    Structural and functional connectional fingerprints in mild cognitive impairment and Alzheimer's disease patients.
    PLoS One. 2017;12:e0173426.
    PubMed     Abstract available


  220. LIN TW, Chang CF, Chang YJ, Liao YH, et al
    Alzheimer's amyloid-beta A2T variant and its N-terminal peptides inhibit amyloid-beta fibrillization and rescue the induced cytotoxicity.
    PLoS One. 2017;12:e0174561.
    PubMed     Abstract available


  221. TU MC, Lo CP, Huang CF, Hsu YH, et al
    Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer's disease and normal ageing.
    PLoS One. 2017;12:e0175143.
    PubMed     Abstract available


  222. VAN GIJSEL-BONNELLO M, Baranger K, Benech P, Rivera S, et al
    Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.
    PLoS One. 2017;12:e0175369.
    PubMed     Abstract available


  223. KASAI T, Kondo M, Ishii R, Tanaka A, et al
    Abeta levels in the jugular vein and high molecular weight Abeta oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.
    PLoS One. 2017;12:e0174630.
    PubMed     Abstract available


  224. YOSHINAGA T, Nishimata H, Kajiya Y, Yokoyama S, et al
    Combined assessment of serum folate and hemoglobin as biomarkers of brain amyloid beta accumulation.
    PLoS One. 2017;12:e0175854.
    PubMed     Abstract available


  225. HAAKSMA ML, Vilela LR, Marengoni A, Calderon-Larranaga A, et al
    Comorbidity and progression of late onset Alzheimer's disease: A systematic review.
    PLoS One. 2017;12:e0177044.
    PubMed     Abstract available


  226. VALLEJO V, Wyss P, Rampa L, Mitache AV, et al
    Evaluation of a novel Serious Game based assessment tool for patients with Alzheimer's disease.
    PLoS One. 2017;12:e0175999.
    PubMed     Abstract available


  227. TASCONE LDS, Payne ME, MacFall J, Azevedo D, et al
    Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer's disease.
    PLoS One. 2017;12:e0177169.
    PubMed     Abstract available


  228. FANG J, Wang L, Li Y, Lian W, et al
    AlzhCPI: A knowledge base for predicting chemical-protein interactions towards Alzheimer's disease.
    PLoS One. 2017;12:e0178347.
    PubMed     Abstract available


  229. LV F, Yang X, Cui C, Su C, et al
    Exogenous expression of Drp1 plays neuroprotective roles in the Alzheimer's disease in the Abeta42 transgenic Drosophila model.
    PLoS One. 2017;12:e0176183.
    PubMed     Abstract available


  230. CHRISTENSEN A, Pike CJ
    Age-dependent regulation of obesity and Alzheimer-related outcomes by hormone therapy in female 3xTg-AD mice.
    PLoS One. 2017;12:e0178490.
    PubMed     Abstract available


  231. LEE SE, Hyun H, Park MR, Choi Y, et al
    Production of transgenic pig as an Alzheimer's disease model using a multi-cistronic vector system.
    PLoS One. 2017;12:e0177933.
    PubMed     Abstract available


  232. KAZEMIFAR S, Manning KY, Rajakumar N, Gomez FA, et al
    Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease.
    PLoS One. 2017;12:e0178529.
    PubMed     Abstract available


  233. CHIU PY, Wang CW, Tsai CT, Li SH, et al
    Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease.
    PLoS One. 2017;12:e0179399.
    PubMed     Abstract available


  234. NEWMAN M, Halter L, Lim A, Lardelli M, et al
    Mitochondrion to endoplasmic reticulum apposition length in zebrafish embryo spinal progenitors is unchanged in response to perturbations associated with Alzheimer's disease.
    PLoS One. 2017;12:e0179859.
    PubMed     Abstract available


  235. BOWLES EJA, Walker RL, Anderson ML, Dublin S, et al
    Risk of Alzheimer's disease or dementia following a cancer diagnosis.
    PLoS One. 2017;12:e0179857.
    PubMed     Abstract available


  236. FANIA C, Arosio B, Capitanio D, Torretta E, et al
    Protein signature in cerebrospinal fluid and serum of Alzheimer's disease patients: The case of apolipoprotein A-1 proteoforms.
    PLoS One. 2017;12:e0179280.
    PubMed     Abstract available


  237. XING HY, Li B, Peng D, Wang CY, et al
    A novel monoclonal antibody against the N-terminus of Abeta1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    PLoS One. 2017;12:e0180076.
    PubMed     Abstract available


  238. MODI KK, Jana A, Ghosh S, Watson R, et al
    Correction: A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease.
    PLoS One. 2017;12:e0180602.
    PubMed     Abstract available


  239. HAN Z, Huang H, Gao Y, Huang Q, et al
    Functional annotation of Alzheimer's disease associated loci revealed by GWASs.
    PLoS One. 2017;12:e0179677.
    PubMed     Abstract available


  240. YU L, Lutz MW, Wilson RS, Burns DK, et al
    APOE epsilon4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
    PLoS One. 2017;12:e0180356.
    PubMed     Abstract available


  241. MASTROENI D, Sekar S, Nolz J, Delvaux E, et al
    ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.
    PLoS One. 2017;12:e0177814.
    PubMed     Abstract available


  242. KONG W, Mou X, Deng J, Di B, et al
    Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation.
    PLoS One. 2017;12:e0180337.
    PubMed     Abstract available


  243. GUAN C, Dang R, Cui Y, Liu L, et al
    Characterization of plasma metal profiles in Alzheimer's disease using multivariate statistical analysis.
    PLoS One. 2017;12:e0178271.
    PubMed     Abstract available


  244. ITOH Y, Voskuhl RR
    Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
    PLoS One. 2017;12:e0181349.
    PubMed     Abstract available


  245. ZHANG C, Rissman RA
    Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice.
    PLoS One. 2017;12:e0181367.
    PubMed     Abstract available


  246. LLANO DA, Bundela S, Mudar RA, Devanarayan V, et al
    A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.
    PLoS One. 2017;12:e0182098.
    PubMed     Abstract available


  247. DROLLE E, Negoda A, Hammond K, Pavlov E, et al
    Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease.
    PLoS One. 2017;12:e0182194.
    PubMed     Abstract available


  248. YASAR S, Jusue-Torres I, Lu J, Robison J, et al
    Alzheimer's disease pathology and shunt surgery outcome in normal pressure hydrocephalus.
    PLoS One. 2017;12:e0182288.
    PubMed     Abstract available


  249. PARK KW, Kim EJ, Han HJ, Shim YS, et al
    Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial.
    PLoS One. 2017;12:e0182123.
    PubMed     Abstract available


  250. FRUZANGOHAR M, Ebrahimie E, Adelson DL
    A novel hypothesis-unbiased method for Gene Ontology enrichment based on transcriptome data.
    PLoS One. 2017;12:e0170486.
    PubMed     Abstract available


  251. GOCH W, Bal W
    Numerical Simulations Reveal Randomness of Cu(II) Induced Abeta Peptide Dimerization under Conditions Present in Glutamatergic Synapses.
    PLoS One. 2017;12:e0170749.
    PubMed     Abstract available


  252. ARRAZOLA MS, Ramos-Fernandez E, Cisternas P, Ordenes D, et al
    Wnt Signaling Prevents the Abeta Oligomer-Induced Mitochondrial Permeability Transition Pore Opening Preserving Mitochondrial Structure in Hippocampal Neurons.
    PLoS One. 2017;12:e0168840.
    PubMed     Abstract available


  253. BARTEL F, Vrenken H, Bijma F, Barkhof F, et al
    Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentations.
    PLoS One. 2017;12:e0166785.
    PubMed     Abstract available


  254. SERRANO-POZO A, Sanchez-Garcia MA, Heras-Garvin A, March-Diaz R, et al
    Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-beta Peptide Generation In Vivo.
    PLoS One. 2017;12:e0170345.
    PubMed     Abstract available


  255. LIANG J, Kulasiri D, Samarasinghe S
    Computational investigation of Amyloid-beta-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer's disease.
    PLoS One. 2017;12:e0182743.
    PubMed     Abstract available


  256. VAN KAMPEN JM, Kay DG
    Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer's disease.
    PLoS One. 2017;12:e0182896.
    PubMed     Abstract available


  257. WANG H, Williams D, Griffin J, Saito T, et al
    Time-course global proteome analyses reveal an inverse correlation between Abeta burden and immunoglobulin M levels in the APPNL-F mouse model of Alzheimer disease.
    PLoS One. 2017;12:e0182844.
    PubMed     Abstract available


  258. CHEN R, Chan PT, Chu H, Lin YC, et al
    Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis.
    PLoS One. 2017;12:e0183586.
    PubMed     Abstract available


  259. SHI JM, Pei J, Liu EQ, Zhang L, et al
    Bis(sulfosuccinimidyl) suberate (BS3) crosslinking analysis of the behavior of amyloid-beta peptide in solution and in phospholipid membranes.
    PLoS One. 2017;12:e0173871.
    PubMed     Abstract available


  260. LI T, Xie Y, Bowe B, Xian H, et al
    Serum phosphorus levels and risk of incident dementia.
    PLoS One. 2017;12:e0171377.
    PubMed     Abstract available


  261. LI T, Li W, Yang Y, Zhang W, et al
    Classification of brain disease in magnetic resonance images using two-stage local feature fusion.
    PLoS One. 2017;12:e0171749.
    PubMed     Abstract available


  262. PARK HY, Park JW, Song HJ, Sohn HS, et al
    The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.
    PLoS One. 2017;12:e0169463.
    PubMed     Abstract available


  263. NICHOLLS SB, DeVos SL, Commins C, Nobuhara C, et al
    Characterization of TauC3 antibody and demonstration of its potential to block tau propagation.
    PLoS One. 2017;12:e0177914.
    PubMed     Abstract available


  264. JOHANSSON P, Almqvist EG, Wallin A, Johansson JO, et al
    Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.
    PLoS One. 2017;12:e0176760.
    PubMed     Abstract available


  265. JOE IS, Kim JH, Kim H, Hong JH, et al
    Cyclin Y-mediated transcript profiling reveals several important functional pathways regulated by Cyclin Y in hippocampal neurons.
    PLoS One. 2017;12:e0172547.
    PubMed     Abstract available


  266. LIU T, Lee M, Ban JJ, Im W, et al
    Cytosolic Extract of Human Adipose Stem Cells Reverses the Amyloid Beta-Induced Mitochondrial Apoptosis via P53/Foxo3a Pathway.
    PLoS One. 2017;12:e0168859.
    PubMed     Abstract available


  267. LIN HC, Xirasagar S, Lee HC, Huang CC, et al
    Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder.
    PLoS One. 2017;12:e0179312.
    PubMed     Abstract available


  268. CHUNG MC, Yu TM, Shu KH, Wu MJ, et al
    Hyponatremia and increased risk of dementia: A population-based retrospective cohort study.
    PLoS One. 2017;12:e0178977.
    PubMed     Abstract available


  269. TUGAEVA KV, Tsvetkov PO, Sluchanko NN
    Bacterial co-expression of human Tau protein with protein kinase A and 14-3-3 for studies of 14-3-3/phospho-Tau interaction.
    PLoS One. 2017;12:e0178933.
    PubMed     Abstract available


  270. AKHTAR RS, Xie SX, Chen YJ, Rick J, et al
    Regional brain amyloid-beta accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia.
    PLoS One. 2017;12:e0177924.
    PubMed     Abstract available


  271. SVARD D, Nilsson M, Lampinen B, Latt J, et al
    The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer's disease.
    PLoS One. 2017;12:e0185239.
    PubMed     Abstract available


  272. HAN F, Zhuang TT, Chen JJ, Zhu XL, et al
    Novel derivative of Paeonol, Paeononlsilatie sodium, alleviates behavioral damage and hippocampal dendritic injury in Alzheimer's disease concurrent with cofilin1/phosphorylated-cofilin1 and RAC1/CDC42 alterations in rats.
    PLoS One. 2017;12:e0185102.
    PubMed     Abstract available


  273. KHAYER N, Marashi SA, Mirzaie M, Goshadrou F, et al
    Three-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic mice.
    PLoS One. 2017;12:e0184697.
    PubMed     Abstract available


  274. RAHMAN A, Lamberty Y, Schenker E, Cella M, et al
    Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus).
    PLoS One. 2017;12:e0184822.
    PubMed     Abstract available


  275. SHENG C, Xia M, Yu H, Huang Y, et al
    Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.
    PLoS One. 2017;12:e0179823.
    PubMed     Abstract available


  276. DANZIGER SA, Miller LR, Singh K, Whitney GA, et al
    An indicator cell assay for blood-based diagnostics.
    PLoS One. 2017;12:e0178608.
    PubMed     Abstract available


  277. MABROUK R, Strafella AP, Knezevic D, Ghadery C, et al
    Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function.
    PLoS One. 2017;12:e0177785.
    PubMed     Abstract available


  278. CHERRY JD, Stein TD, Tripodis Y, Alvarez VE, et al
    CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease.
    PLoS One. 2017;12:e0185541.
    PubMed     Abstract available


  279. WU YH, Vidal JS, de Rotrou J, Sikkes SAM, et al
    Can a tablet-based cancellation test identify cognitive impairment in older adults?
    PLoS One. 2017;12:e0181809.
    PubMed     Abstract available


  280. PERSYN E, Karakachoff M, Le Scouarnec S, Le Clezio C, et al
    DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease.
    PLoS One. 2017;12:e0179364.
    PubMed     Abstract available


  281. YI D, Seo EH, Han JY, Sohn BK, et al
    Development of the Korean Adult Reading Test (KART) to estimate premorbid intelligence in dementia patients.
    PLoS One. 2017;12:e0181523.
    PubMed     Abstract available


  282. MIKI STEIN A, Munive V, Fernandez AM, Nunez A, et al
    Acute exercise does not modify brain activity and memory performance in APP/PS1 mice.
    PLoS One. 2017;12:e0178247.
    PubMed     Abstract available


  283. REHKER J, Rodhe J, Nesbitt RR, Boyle EA, et al
    Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants.
    PLoS One. 2017;12:e0185777.
    PubMed     Abstract available


  284. CHAN YC, Hwang JH
    Effects of Spirulina on the functions and redox status of auditory system in senescence-accelerated prone-8 mice.
    PLoS One. 2017;12:e0178916.
    PubMed     Abstract available


  285. MOSCONI L, Berti V, Guyara-Quinn C, McHugh P, et al
    Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
    PLoS One. 2017;12:e0185926.
    PubMed     Abstract available


  286. MATONE A, Derlindati E, Marchetti L, Spigoni V, et al
    Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects.
    PLoS One. 2017;12:e0182559.
    PubMed     Abstract available


  287. MIJALKOV M, Kakaei E, Pereira JB, Westman E, et al
    BRAPH: A graph theory software for the analysis of brain connectivity.
    PLoS One. 2017;12:e0178798.
    PubMed     Abstract available


  288. PERSSON K, Eldholm RS, Barca ML, Cavallin L, et al
    MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis.
    PLoS One. 2017;12:e0186595.
    PubMed     Abstract available


  289. ANASTASIOU CA, Yannakoulia M, Kosmidis MH, Dardiotis E, et al
    Mediterranean diet and cognitive health: Initial results from the Hellenic Longitudinal Investigation of Ageing and Diet.
    PLoS One. 2017;12:e0182048.
    PubMed     Abstract available


  290. SOLDNER CA, Sticht H, Horn AHC
    Role of the N-terminus for the stability of an amyloid-beta fibril with three-fold symmetry.
    PLoS One. 2017;12:e0186347.
    PubMed     Abstract available


  291. PARK HJ, Ryu D, Parmar M, Giasson BI, et al
    The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome.
    PLoS One. 2017;12:e0184262.
    PubMed     Abstract available


  292. YI B, Jahangir A, Evans AK, Briggs D, et al
    Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders.
    PLoS One. 2017;12:e0180319.
    PubMed     Abstract available


  293. YAO X, Yan J, Ginda M, Borner K, et al
    Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative.
    PLoS One. 2017;12:e0186095.
    PubMed     Abstract available


  294. MIHELCIC M, Simic G, Babic Leko M, Lavrac N, et al
    Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.
    PLoS One. 2017;12:e0187364.
    PubMed     Abstract available


  295. CHIU PY, Hsu MH, Wang CW, Tsai CT, et al
    Visual hallucinations in Alzheimer's disease is significantly associated with clinical diagnostic features of dementia with Lewy bodies.
    PLoS One. 2017;12:e0186886.
    PubMed     Abstract available


  296. RASERO J, Amoroso N, La Rocca M, Tangaro S, et al
    Multivariate regression analysis of structural MRI connectivity matrices in Alzheimer's disease.
    PLoS One. 2017;12:e0187281.
    PubMed     Abstract available


  297. HOHMAN TJ, Dumitrescu L, Oksol A, Wagener M, et al
    APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease.
    PLoS One. 2017;12:e0188501.
    PubMed     Abstract available


  298. RUDOBECK E, Bellone JA, Szucs A, Bonnick K, et al
    Low-dose proton radiation effects in a transgenic mouse model of Alzheimer's disease - Implications for space travel.
    PLoS One. 2017;12:e0186168.
    PubMed     Abstract available


  299. CHU TH, Cummins K, Sparling JS, Tsutsui S, et al
    Axonal and myelinic pathology in 5xFAD Alzheimer's mouse spinal cord.
    PLoS One. 2017;12:e0188218.
    PubMed     Abstract available


  300. OTTOY J, Verhaeghe J, Niemantsverdriet E, Engelborghs S, et al
    A simulation study on the impact of the blood flow-dependent component in [18F]AV45 SUVR in Alzheimer's disease.
    PLoS One. 2017;12:e0189155.
    PubMed     Abstract available


  301. WANG L, Hubbard RA, Walker RL, Lee EB, et al
    Assessing robustness of hazard ratio estimates to outcome misclassification in longitudinal panel studies with application to Alzheimer's disease.
    PLoS One. 2017;12:e0190107.
    PubMed     Abstract available


  302. ELNAGAR MR, Walls AB, Helal GK, Hamada FM, et al
    Probing the putative alpha7 nAChR/NMDAR complex in human and murine cortex and hippocampus: Different degrees of complex formation in healthy and Alzheimer brain tissue.
    PLoS One. 2017;12:e0189513.
    PubMed     Abstract available


  303. WEED MR, Polino J, Signor L, Bookbinder M, et al
    Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
    PLoS One. 2017;12:e0187609.
    PubMed     Abstract available


  304. ASAM K, Staniszewski A, Zhang H, Melideo SL, et al
    Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.
    PLoS One. 2017;12:e0189413.
    PubMed     Abstract available


  305. MONTOLIU-GAYA L, Mulder SD, Veerhuis R, Villegas S, et al
    Effects of an Abeta-antibody fragment on Abeta aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
    PLoS One. 2017;12:e0188191.
    PubMed     Abstract available


  306. HA S, Kim I, Takata T, Kinouchi T, et al
    Identification of -amino acid-containing peptides in human serum.
    PLoS One. 2017;12:e0189972.
    PubMed     Abstract available


    January 2016
  307. RAJA WK, Mungenast AE, Lin YT, Ko T, et al
    Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
    PLoS One. 2016;11:e0161969.
    PubMed     Abstract available


  308. CHEN PT, Chen CL, Lin LT, Lo CH, et al
    Design of Peptide Substrate for Sensitively and Specifically Detecting Two Abeta-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
    PLoS One. 2016;11:e0153360.
    PubMed     Abstract available


  309. SU Y, Blazey TM, Owen CJ, Christensen JJ, et al
    Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.
    PLoS One. 2016;11:e0163669.
    PubMed     Abstract available


  310. LEE HK, Velazquez Sanchez C, Chen M, Morin PJ, et al
    Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells.
    PLoS One. 2016;11:e0163072.
    PubMed     Abstract available


  311. BAEK MJ, Kim K, Park YH, Kim S, et al
    The Validity and Reliability of the Mini-Mental State Examination-2 for Detecting Mild Cognitive Impairment and Alzheimer's Disease in a Korean Population.
    PLoS One. 2016;11:e0163792.
    PubMed     Abstract available


  312. CORREA MS, Giacobbo BL, Vedovelli K, Lima DB, et al
    Age Effects on Cognitive and Physiological Parameters in Familial Caregivers of Alzheimer's Disease Patients.
    PLoS One. 2016;11:e0162619.
    PubMed     Abstract available


  313. SASAOKA S, Matsui T, Hane Y, Abe J, et al
    Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events.
    PLoS One. 2016;11:e0164309.
    PubMed     Abstract available


  314. MORRONE CD, Thomason LA, Brown ME, Aubert I, et al
    Effects of Neurotrophic Support and Amyloid-Targeted Combined Therapy on Adult Hippocampal Neurogenesis in a Transgenic Model of Alzheimer's Disease.
    PLoS One. 2016;11:e0165393.
    PubMed     Abstract available


  315. VISHNU VY, Modi M, Sharma S, Mohanty M, et al
    Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India.
    PLoS One. 2016;11:e0166369.
    PubMed     Abstract available


  316. CERMAK S, Kosicek M, Mladenovic-Djordjevic A, Smiljanic K, et al
    Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
    PLoS One. 2016;11:e0167428.
    PubMed     Abstract available


  317. DAMMERS C, Yolcu D, Kukuk L, Willbold D, et al
    Selection and Characterization of Tau Binding -Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.
    PLoS One. 2016;11:e0167432.
    PubMed     Abstract available


  318. ZHANG M, Schmitt-Ulms G, Sato C, Xi Z, et al
    Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
    PLoS One. 2016;11:e0168812.
    PubMed     Abstract available


  319. KAO LT, Kang JH, Lin HC, Huang CC, et al
    Rheumatoid Arthritis Was Negatively Associated with Alzheimer's Disease: A Population-Based Case-Control Study.
    PLoS One. 2016;11:e0168106.
    PubMed     Abstract available


  320. STUDNICKI M, Wozniak G, Stepkowski D
    The Calculator of Anti-Alzheimer's Diet. Macronutrients.
    PLoS One. 2016;11:e0168385.
    PubMed     Abstract available


  321. KOBAYASHI N, Shinagawa S, Nagata T, Shimada K, et al
    Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    PLoS One. 2016;11:e0168816.
    PubMed     Abstract available


  322. PEREZ C, Ziburkus J, Ullah G
    Analyzing and Modeling the Dysfunction of Inhibitory Neurons in Alzheimer's Disease.
    PLoS One. 2016;11:e0168800.
    PubMed     Abstract available


  323. KRUSE N, Schlossmacher MG, Schulz-Schaeffer WJ, Vanmechelen E, et al
    A First Tetraplex Assay for the Simultaneous Quantification of Total alpha-Synuclein, Tau, beta-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    PLoS One. 2016;11:e0153564.
    PubMed     Abstract available


  324. LIANG CT, Huang HB, Wang CC, Chen YR, et al
    L17A/F19A Substitutions Augment the alpha-Helicity of beta-Amyloid Peptide Discordant Segment.
    PLoS One. 2016;11:e0154327.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: